Psp Research LLC Top Holdings and 13F Report (2026) About Psp Research LLCInvestment ActivityPsp Research LLC has $187.88 million in total holdings as of June 30, 2026.Psp Research LLC owns shares of 75 different stocks, but just 2 companies or ETFs make up 80% of its holdings.Approximately 25.49% of the portfolio was purchased this quarter.About 8.80% of the portfolio was sold this quarter.This quarter, Psp Research LLC has purchased 79 new stocks and bought additional shares in 1 stock.Psp Research LLC sold shares of 30 stocks and completely divested from 15 stocks this quarter.Largest Holdings SPDR S&P Biotech ETF $90,202,500iShares 0-3 Month Treasury Bond ETF $70,469,000Royalty Pharma $616,770Nurix Therapeutics $606,500Incyte $600,808 Largest New Holdings this Quarter K08588103 - ASCENDIS PHARMA A/S $400,080 Holding53635D202 - Liquidia $398,650 Holding501147102 - Krystal Biotech $257,196 Holding04272N102 - ARRIVENT BIOPHARMA INC $244,604 HoldingG50871105 - Jazz Pharmaceuticals $233,982 Holding Largest Purchases this Quarter SPDR S&P Biotech ETF 285,100 shares (about $45.12M)ASCENDIS PHARMA A/S 1,500 shares (about $400.08K)Liquidia 5,000 shares (about $398.65K)Krystal Biotech 692 shares (about $257.20K)ARRIVENT BIOPHARMA INC 7,041 shares (about $244.60K) Largest Sales this Quarter DEFINIUM THERAPEUTICS INC 24,800 shares (about $1.17M)Compass Pathways 53,000 shares (about $749.95K)Axsome Therapeutics 1,845 shares (about $451.60K)Mirum Pharmaceuticals 2,500 shares (about $292.68K)Kymera Therapeutics 2,300 shares (about $263.74K) Sector Allocation Over TimeMap of 500 Largest Holdings ofPsp Research LLC Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorXBISPDR S&P Biotech ETF$90,202,500$45,117,075 â–²100.1%570,00048.0%ETFSGOViShares 0-3 Month Treasury Bond ETF$70,469,0000.0%700,00037.5%ETFRPRXRoyalty Pharma$616,7700.0%11,0000.3%HealthcareNRIXNurix Therapeutics$606,500$89,762 â–¼-12.9%25,0000.3%HealthcareINCYIncyte$600,8080.0%5,3000.3%HealthcareARGXargenex$594,7010.0%6410.3%HealthcareIRONDisc Medicine$585,1200.0%8,0000.3%HealthcareRAPPORT THERAPEUTICS INC$583,3800.0%14,0000.3%COMRAREUltragenyx Pharmaceutical$567,630$170,289 â–¼-23.1%17,0000.3%HealthcareTRVITrevi Therapeutics$559,5000.0%30,0000.3%HealthcareGLUEMonte Rosa Therapeutics$556,600$121,000 â–¼-17.9%23,0000.3%HealthcareTGTXTG Therapeutics$549,400$164,820 â–¼-23.1%10,0000.3%HealthcareHALOHalozyme Therapeutics$547,890$80,305 â–¼-12.8%7,0000.3%HealthcareIONSIonis Pharmaceuticals$539,1720.0%6,8000.3%HealthcarePHVSPharvaris$518,700$172,900 â–¼-25.0%15,0000.3%HealthcareARQTArcutis Biotherapeutics$516,5340.0%19,7000.3%HealthcareAUPHAurinia Pharmaceuticals$509,1000.0%30,0000.3%HealthcareNBIXNeurocrine Biosciences$505,605$142,918 â–¼-22.0%3,0000.3%HealthcareIMVTImmunovant$500,890$238,886 â–¼-32.3%13,0000.3%HealthcareACADACADIA Pharmaceuticals$500,0800.0%19,7660.3%HealthcarePTCTPTC Therapeutics$489,4200.0%6,0000.3%HealthcareCLDXCelldex Therapeutics$483,7300.0%13,0000.3%HealthcareIMCRImmunocore$480,7270.0%15,1410.3%HealthcareDEFINIUM THERAPEUTICS INC$470,400$1,166,592 â–¼-71.3%10,0000.3%COM SHSCOGTCogent Biosciences$464,4000.0%12,0000.2%HealthcareKYMRKymera Therapeutics$458,680$263,741 â–¼-36.5%4,0000.2%HealthcareDYNE THERAPEUTICS INC$444,2000.0%20,0000.2%COMALNYAlnylam Pharmaceuticals$441,0090.0%1,4650.2%HealthcareTARSTarsus Pharmaceuticals$440,5800.0%7,0000.2%HealthcareSNDXSyndax Pharmaceuticals$437,2000.0%20,0000.2%HealthcareEXELExelixis$435,280$214,811 â–¼-33.0%8,0000.2%HealthcareCRNXCrinetics Pharmaceuticals$411,6200.0%11,0000.2%HealthcareNAMSNewAmsterdam Pharma$406,680$101,670 â–¼-20.0%12,0000.2%HealthcareASCENDIS PHARMA A/S$400,080$400,080 â–²New Holding1,5000.2%ORD SHSLQDALiquidia$398,650$398,650 â–²New Holding5,0000.2%HealthcareSTOKStoke Therapeutics$392,6400.0%12,0000.2%HealthcareVKTXViking Therapeutics$390,100$195,050 â–¼-33.3%10,0000.2%HealthcareIMNMImmunome$381,420$42,380 â–¼-10.0%18,0000.2%HealthcarePTGXProtagonist Therapeutics$367,7400.0%3,0000.2%HealthcareHRMYHarmony Biosciences$364,100$155,944 â–¼-30.0%10,0000.2%HealthcareELVNEnliven Therapeutics$355,2500.0%7,0000.2%HealthcareSPYRE THERAPEUTICS INC$355,120$102,896 â–¼-22.5%4,0000.2%COM NEWNTLAIntellia Therapeutics$338,400$116,748 â–¼-25.7%20,0000.2%HealthcareMDGLMadrigal Pharmaceuticals$322,1700.0%6000.2%HealthcareKINIKSA PHARMACEUTICALS INTL$319,750$255,800 â–¼-44.4%5,0000.2%ORD SHS CL AALKSAlkermes$314,3700.0%6,0000.2%HealthcareTNGXTango Therapeutics$312,600$137,544 â–¼-30.6%10,0000.2%HealthcareARDXArdelyx$306,000$102,000 â–¼-25.0%60,0000.2%HealthcareVERAVera Therapeutics$300,370$128,730 â–¼-30.0%7,0000.2%HealthcareMIRMMirum Pharmaceuticals$292,675$292,675 â–¼-50.0%2,5000.2%HealthcareORUKA THERAPEUTICS INC$285,510$187,295 â–¼-39.6%3,0000.2%COMSUPNSupernus Pharmaceuticals$279,0600.0%6,0000.1%HealthcareCRSPCRISPR Therapeutics$272,700$245,430 â–¼-47.4%5,0000.1%HealthcareZYMEWORKS INC$261,4000.0%10,0000.1%COMKRYSKrystal Biotech$257,196$257,196 â–²New Holding6920.1%HealthcareCMPSCompass Pathways$254,700$749,950 â–¼-74.6%18,0000.1%HealthcareXENEXenon Pharmaceuticals$253,5120.0%4,2000.1%HealthcareAXSMAxsome Therapeutics$244,770$451,601 â–¼-64.9%1,0000.1%HealthcareARRIVENT BIOPHARMA INC$244,604$244,604 â–²New Holding7,0410.1%COMDIANTHUS THERAPEUTICS INC$243,700$243,700 â–¼-50.0%2,5000.1%COMJAZZJazz Pharmaceuticals$233,982$233,982 â–²New Holding9710.1%HealthcareKODKodiak Sciences$233,760$155,840 â–¼-40.0%6,0000.1%HealthcareRVMDRevolution Medicines$224,736$224,736 â–²New Holding1,2000.1%HealthcareBBIOBridgeBio Pharma$223,440$223,440 â–¼-50.0%3,0000.1%HealthcareRYTMRhythm Pharmaceuticals$222,060$222,060 â–²New Holding2,0000.1%HealthcareDNLIDenali Therapeutics$217,668$217,668 â–²New Holding8,4630.1%HealthcareARWRArrowhead Pharmaceuticals$211,926$211,926 â–²New Holding2,6000.1%HealthcareSRRKScholar Rock$210,485$210,485 â–²New Holding3,8270.1%HealthcareEWTXEdgewise Therapeutics$203,150$60,945 â–¼-23.1%5,0000.1%HealthcareAMLXAmylyx Pharmaceuticals$194,6500.0%10,8380.1%HealthcareCTMXCytomX Therapeutics$147,750$147,750 â–²New Holding39,4000.1%HealthcareOCULOcular Therapeutix$147,3000.0%15,0000.1%HealthcareEYPTEyepoint Pharmaceuticals$143,0000.0%10,0000.1%HealthcareORICOric Pharmaceuticals$140,7900.0%13,0000.1%HealthcareOLMAOlema Pharmaceuticals$125,1000.0%10,0000.1%HealthcareSERASera Prognostics$0$4,865,271 â–¼-100.0%00.0%HealthcareTYRATyra Biosciences$0$612,800 â–¼-100.0%00.0%HealthcareASNDAscendis Pharma A/S$0$571,825 â–¼-100.0%00.0%HealthcareCYTKCytokinetics$0$547,053 â–¼-100.0%00.0%HealthcareAGIOAgios Pharmaceuticals$0$507,450 â–¼-100.0%00.0%HealthcarePRAXIS PRECISION MEDICINES I$0$483,285 â–¼-100.0%00.0%COM NEWINHIBRX BIOSCIENCES INC$0$465,702 â–¼-100.0%00.0%COMERASErasca$0$280,351 â–¼-100.0%00.0%HealthcareCELCCelcuity$0$228,280 â–¼-100.0%00.0%HealthcareKALVKalVista Pharmaceuticals$0$217,303 â–¼-100.0%00.0%HealthcareLEGNLegend Biotech$0$217,080 â–¼-100.0%00.0%HealthcareAPOGEE THERAPEUTICS INC$0$210,425 â–¼-100.0%00.0%COMUTHRUnited Therapeutics$0$207,543 â–¼-100.0%00.0%HealthcareSMMTSummit Therapeutics$0$193,828 â–¼-100.0%00.0%HealthcareCMPXCompass Therapeutics$0$158,700 â–¼-100.0%00.0%HealthcareShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
